Globus Medical Inc news

   Watch this stock
Showing stories 1 - 10 of about 71   

Articles published

GMED 26.40 +0.40 (1.52%)
price chart
Globus Medical Inc. (GMED) to Release Quarterly Earnings on Tuesday
Globus Medical logo Globus Medical Inc. (NYSE:GMED) is scheduled to announce its earnings results after the market closes on Tuesday, July 26th.
Two Movers within Analysts Observation: Cara Therapeutics, Inc. (NASDAQ:CARA ...  Street Updates
Winning Stock for the Quarter: Globus Medical, Inc. (NYSE:GMED)  Engelwood Daily
Globus Medical Inc (GMED)'s Inside Job
Last February spinal orthopedic device maker Globus Medical purchased Branch Medical Group, a key supplier and contract manufacturing operation based just three miles away from its Audubon, Pa.
SIRF: Golbus Medical's 'Inside Job'  Benzinga
Short-term Advances Pleasing Investors in Globus Medical, Inc. (NYSE:GMED)
Investors holding shares of Globus Medical, Inc. (NYSE:GMED) have been treated this week to nice gains as shares are up 5.05% over the past five trading days.
Stock Slipping Lower This Year Globus Medical, Inc. (NYSE:GMED)
Investors in Globus Medical, Inc. (NYSE:GMED) stock continue to shudder this year as the stock has been unable to gain any traction.
Wellington Management Group LLP Purchases 352562 Shares of Globus Medical Inc ...
Globus Medical logo Wellington Management Group LLP boosted its stake in Globus Medical Inc. (NYSE:GMED) by 4.9% during the first quarter, according to its most recent disclosure with the SEC.
Globus Medical, Inc. (NYSE:GMED): Sell-Side Ratings and Company Earnings Glance
As companies start to report earnings, investors and analysts will be watching to see if the company meets or beats predictions after the next release.
Globus Medical, Inc. versus LDR Holding Corporation Head to Head Compare
Globus Medical, Inc. has a substantially higher fundamental rating then LDR Holding Corporation which has an impact on the head-to-head comparison.
Globus Medical Inc (GMED) Receives Overweight Rating from Piper Jaffray
Globus Medical logo Globus Medical Inc (NYSE:GMED)'s stock had its “overweight” rating restated by equities research analysts at Piper Jaffray in a research report issued to clients and investors on Saturday.
Is Globus Medical Inc (NYSE:GMED) a Valuable Stock?
Globus Medical Inc (NYSE:GMED) stock is currently trading 17.14% below its 52-week-high, 17.29% above its 52-week-low. The 1-year stock price history is in the range of $20.48 - $28.99.
Zacks Estimates EPS of $0.31 For Globus Medical, Inc. (NYSE:GMED)
As of 2017-06-30, Zacks is expecting EPS of $0.31 for Globus Medical, Inc. (NYSE:GMED) for the year ended 2017. The median EPS estimate is $0.31 calculated after taking 3 analyst projections.